Showing results (21-30 of 2,558) with videos related to
Sort By:
Pageof 256
Der Nervenarzt|April 10, 2009
[Progressive multifocal leukoencephalopathy. Undesirable side effect of immunotherapy]H-P Hartung, C Warnke, R Hohlfeld, et al.Der Nervenarzt|November 25, 2010
[Interferon β for multiple sclerosis. How much is good enough?]C Warnke, V I Leussink, B C Kieseier, et al.Der Nervenarzt|January 30, 2010
[4-Aminopyridine (Fampridine). A new attempt for the symptomatic treatment of multiple sclerosis]L Husseini, V I Leussink, B C Kieseier, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|October 18, 2005
The pentapeptide QYNAD does not inhibit neuronal network activityF Otto, B C Kieseier, P Görtz, et al.European Journal of Neurology|January 30, 2009
Cladribine impedes in vitro migration of mononuclear cells: a possible implication for treating multiple sclerosisT Kopadze, M Döbert, V I Leussink, et al.Der Nervenarzt|November 1, 2011
[Alemtuzumab: a further option for treatment of multiple sclerosis]T Menge, B C Kieseier, C Warnke, et al.Der Nervenarzt|April 7, 2005
[Blocking adhesion molecules with natalizumab in multiple sclerosis]B Schreiner, B C Kieseier, H-P Hartung, et al.Der Nervenarzt|February 3, 2007
[Plasma exchange as a therapeutic option in neurological disorders]H C Lehmann, H P Hartung, G R Hetzel, et al.Der Nervenarzt|April 3, 2015
[Pegylated interferon beta 1a. A new therapy option for treatment of relapsing-remitting multiple sclerosis]V I Leussink, C Warnke, B Tackenberg, et al.Der Nervenarzt|August 9, 2003
[Cholesterol-reducing medications-a new therapeutic option for multiple sclerosis? Statins as immunomodulators]O Neuhaus, H Wiendl, B C Kieseier, et al.Pageof 256